Please assess the completion status of the following clinical trial:

Trial Title: A Study to Compare Methodologies for Assessing Glucose-Dependent Insulin Secretion (0000-104)(COMPLETED)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Subject has a Body Mass Index (BMI) of less than or equal to 26 kg/m2 at screening~* Subject is judged to be in good health~* Subject has been a nonsmoker for at least 3 months~* Subject is willing to avoid strenuous physical activity for the duration of the study~Exclusion Criteria:~* Subject has a history of high blood pressure requiring treatment~* Subject has a history of diabetes or a family history of diabetes mellitus~* Subject is unable to discontinue all prescription and non-prescription drugs for duration of study~* Subject consumes more than 3 alcoholic beverages per day~* Subject consumes more than 6 servings of caffeinated beverages per day (1 serving = 120mg caffeine)~* Subject has had major surgery or has donated or loss 1 unit of blood within 4 weeks of screening~* Subject has multiple and/or severe allergies to foods or drugs~* Subject is a regular user of illegal drugs~* Subject is unwilling or unable to consume the standardized meals during the study and/or is on a carbohydrate restricted diet

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): exenatide 5mcg
- 2 (Type: ACTIVE_COMPARATOR): exenatide 1.5mcg
- 3 (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).